Lipophosphonoxins, method of their preparation and use
    2.
    发明公开
    Lipophosphonoxins, method of their preparation and use 有权
    Lipophosphonoxine,Verfahren zur Herstellung und Verwendung

    公开(公告)号:EP2527351A1

    公开(公告)日:2012-11-28

    申请号:EP12169491.3

    申请日:2012-05-25

    CPC分类号: C07F9/6561 C07F9/65586

    摘要: The invention discloses lipophosphonoxins of general formula I, wherein R 1 is (C 8 -C 22 )alkyl or hexadecyloxypropyl, tetradecyloxypropyl, tetradecyloxyethyl or hexadecyloxyethyl and R 2 is uracil, thymin or cytosin, R 3 is selected from group comprising compounds of general formula II and III, where R 4 is H or CH 2 OH, R 5 is H or OH, R 6 is H or OH, R 7 is H or CH 2 OH, R 8 is H or CH 2 OH, R 9 is H or OH, R 10 is H or OH, R 11 is H or OH, R 12 is H or CH 2 OH. Described are also diastereomers and mixtures of diastereomers of compounds of general formula I as well as corresponding pharmaceutically acceptable salts and hydrates and also a suitable method of preparation of such compounds. All described compounds of general formula I can be used as antibacterial agents or as active components of disinfectants and/or of selective in vitro growth media.

    摘要翻译: 本发明公开了通式Ⅰ的脂磷氧化还原剂,其中R 1为(C 8 -C 22)烷基或十六烷氧基丙基,十四烷氧基丙基,十四烷氧基乙基或十六烷氧基乙基,R 2为尿嘧啶,甲氨宁或细胞碱,R 3选自通式 II和III,其中R 4是H或CH 2 OH,R 5是H或OH,R 6是H或OH,R 7是H或CH 2 OH,R 8是H或CH 2 OH,R 9是H 或OH,R 10为H或OH,R 11为H或OH,R 12为H或CH 2 OH。 还描述了通式I化合物的非对映异构体和非对映异构体的混合物,以及相应的药学上可接受的盐和水合物,以及这些化合物的合适的制备方法。 所有描述的通式I化合物可用作抗菌剂或作为消毒剂和/或选择性体外生长培养基的活性成分。